Journal of Clinical Epidemiology
Volume 54, Issue 7 , Pages 728-734 , July 2001

Antidepressant use and the risk of breast cancer: A non-association

  • Philip S Wang

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA USA
    • Department of Epidemiology, Harvard School of Public Health, Boston, MA USA
    • Corresponding Author InformationCorresponding author. Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 221 Longwood Avenue, Boston, MA 02115. Tel. 617-278-0930; fax: 617-232-8602.(P.S. Wang)
    • ,
  • Alexander M Walker

      Affiliations

    • Department of Epidemiology, Harvard School of Public Health, Boston, MA USA
    • ,
  • Ming T Tsuang

      Affiliations

    • Department of Epidemiology, Harvard School of Public Health, Boston, MA USA
    • Massachusetts Mental Health Center, Harvard Medical School, Boston, MA USA
    • ,
  • E.John Orav

      Affiliations

    • Clinical Epidemiology Section, Brigham and Women's Hospital, Harvard Medical School, Boston, MA USA
    • ,
  • Raisa Levin

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA USA
    • ,
  • Jerry Avorn

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA USA

Received 14 June 2000 ,Revised 26 September 2000 ,Accepted 23 October 2000.

References 

  1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. Ca Cancer J Clin. 1997;47:5–27
  2. Brandes LJ, Arron RJ, Bogdanovic RP. Stimulation of malignant growth in rodents by antidepressant drugs at clinically-relevant doses. Cancer Res. 1992;52:3796–3800
  3. Hilakivi-Clarke L, Wright A, Lippman ME. Neonatal antidepressant treatment promotes DMBA-induced mammary tumor growth. Proc Am Assoc Cancer Res. 1993;34:84
  4. Wallace RB, Sherman BM, Bean JA. A case-control study of breast cancer and psychotropic drug use. Oncology. 1982;39:279–283
  5. Danielson DA, Jick H, Hunter JR, Stergachis A, Madsen S. Nonestrogenic drugs and breast cancer. Am J Epidemiol. 1982;116:329–332
  6. Kelly JP, Rosenberg L, Rao RS, Palmer JR, Shapiro S. Is antidepressant use associated with the occurrence of breast cancer?. Am J Epidemiol. 1998;147(Suppl):S69
  7. Cotterchio M, Kreiger N, Darlington G, Steingart A. Antidepressant medication use and breast cancer risk. Am J Epidemiol. 2000;151:951–957
  8. Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity (eleven to fifteen years of follow-up). Cancer Res. 1989;49:5736–5747
  9. Harlow BL, Cramer DW. Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer (evidence from two combined case-control studies (Massachusetts, United States)). Cancer Causes Control. 1995;6:130–134
  10. Stoll BA. Psychosomatic factors and tumor growth. In:  Stoll BA editors. Risk factors in breast cancer. Chicago: Year Book Medical Publishers; 1976;p. 196–199
  11. Tzonou A, Day NE, Trichopoulos D, Walker A, Saliaraki M, Papapostolou M, et al. The epidemiology of ovarian cancer in Greece (a case-control study). Eur J Clin Oncol. 1984;20:1045–1052
  12. Weiss SR, McFarland BH, Burkhart GA, Ho PT. Cancer recurrences and secondary primary cancers after the use of antihistamines or antidepressants. Clin Pharmacol Ther. 1998;63:594–599
  13. Hume AL, Barbour MM, Lapane KL, Carleton RA. Is antidepressant use changing? Prevalence and clinical correlates in two New England communities. Pharmacotherapy. 1995;15:78–84
  14. Jaeger H, Morrow GR, Carpenter PJ, Brescia F. A survey of psychotropic drug utilization by patients with advanced neoplastic disease. Gen Hosp Psychiatry. 1985;7:353–360
  15. Cullivan R, Crown J, Walsh N. The use of psychotropic medication in patients referred to a psycho-oncology service. Psycho-Oncology. 1998;7:301–306
  16. Iishi H, Tatsuta M, Miyako B, Taniguchi H. Enhancement by the tricyclic antidepressant, disipramine, of experimental carcinogenesis in rat colon induced by azoxymethane. Carcinogenesis. 1993;14(9):1837–1840
  17. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329:326–331
  18. International classification of diseases, 9th revision, clinical modification. Washington, DC: Public Health Service, U.S. Dept. of Health and Human Services, 1988.
  19. Physicians' current procedural terminology, 4th ed. Chicago, IL: American Medical Association, 1989.
  20. St. Anthony's diagnosis related group working guidebook. Alexandria, VA: St. Anthony Publishing, 1993.
  21. American Psychiatric Association . Practice guideline for major depressive disorder in adults. Am J Psychiatry. 1993;150(Suppl):1–26
  22. In:  Shambaugh EW,  Weiss MA,  Axtell LM editor. Summary staging guide (cancer surveillance, epidemiology, and end results (SEER) program). Bethesda, MD: Department of HEW, NIH; 1977;
  23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies (development and validation). J Chron Dis. 1987;40:373–383
  24. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619
  25. SAS release 6.12. Cary, NC: SAS Institute, 1996.
  26. Kelsey JL. Breast cancer epidemiology. Epidemiol Rev. 1993;15:256–263
  27. Kelsey JL, Horn-Ross P. Breast cancer (magnitude of the problem and descriptive epidemiology). Epidemiol Rev. 1993;15:7–16
  28. Krieger N. Social class and the black/white cross-over in the age-specific incidence of breast cancer (a study linking census-derived data to population based registry records). Am J Epidemiol. 1990;131:804–814
  29. Brinton LA, Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev. 1993;15:66–79
  30. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589–1593
  31. Bodian CA. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev. 1993;15:177–187
  32. Hunter DJ, Willett WC. Diet, body size and breast cancer. Epidemiol Rev. 1993;15:110–132
  33. Lessler JT, Harris BSH. Medicaid data as a source for postmarketing surveillance information, final report. Research Triangle Park, NC: Research Triangle Institute; 1984;
  34. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science. 1990;249:1007–1011
  35. Ames BN. Mutagenesis and carcinogenesis (endogenous and exogenous factors). Environ Mutat. 1989;13:1–12

PII: S0895-4356(00)00354-1

Journal of Clinical Epidemiology
Volume 54, Issue 7 , Pages 728-734 , July 2001

Article Tools